The Makers of Female Viagra Say the Haters Have It All Wrong

Business Insider - Quotes Lisa Schwartz, professor of medicine, on the drug flibanserin, marketed as a pink pill called Addyi, recently approved by the Food and Drug Administration after two failed attempts. Schwartz points out that despite what appeared to be feminist forces helping the approval along, the drug could be considered anti-feminist. "The strongest advocate for women would want good, safe drugs that will really help them," she said.